# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-015047
Filing Date
2023-05-01
Accepted
2023-05-01 17:27:50
Documents
3
Period of Report
2023-05-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdef14a.htm | DEF 14A | 398466
2 |  | proxy_001.jpg | GRAPHIC | 508175
3 |  | proxy_002.jpg | GRAPHIC | 348669
| Complete submission text file | 0001493152-23-015047.txt |  | 1579276

Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40023 | Film No.: 23875356
SIC: 2834 Pharmaceutical Preparations